Recombinant granulocyte - colony stimulating factor ( DrugBank: - )


1 disease
IDDisease name (Link within this page)Number of trials
39Toxic epidermal necrolysis1

39. Toxic epidermal necrolysis


Clinical trials : 13 Drugs : 19 - (DrugBank : 8) / Drug target genes : 11 - Drug target pathways : 103
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT02739295
(ClinicalTrials.gov)
July 20164/4/2016G-CSF in the Treatment of Toxic Epidermal NecrolysisEvaluation of G-CSF as a Treatment of Toxic Epidermal NecrolysisStevens - Johnson SyndromeDrug: recombinant granulocyte - colony stimulating factor;Drug: NaCl 0.9%University of LiegeNULLRecruiting18 YearsN/AAll10Phase 4Belgium